Germano Geno J 4

What Happened

• Geno J. Germano, a director of Harmony Biosciences Holdings, was granted a derivative award on 2026-05-14 for options covering 21,231 shares. The grant shows a $0.00 per-share acquisition price (no cash paid at grant) and is reported as an award (transaction code A).

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (filed within required timeframe).
• Grant size: options covering 21,231 shares; acquisition price reported $0.00; total immediate cash outlay $0.
• Vesting: the stock option vests in 36 equal monthly installments beginning June 14, 2026 (per footnote).
• Shares owned after transaction: not specified in the provided filing.
• Transaction type: derivative award (option grant), not a purchase or sale.

Context

• This was a grant of stock options as compensation/awards rather than a market purchase or sale. The grant creates potential future upside if the stock price rises and vesting conditions are met; it does not represent immediate realized value or insider selling.